Patient Preparation By Medical Technologists

Posted by Admin | Posted in Medical Stuff | Posted on 28-11-2009


Read the rest of this entry »

Antibody Identified in Patients With Autoimmune Pancreatitis

Posted by Admin | Posted in Medical Lawyers | Posted on 26-11-2009

Researchers have identified an antibody that is present in the serum of most patients who have autoimmune pancreatitis and may eventually help in the differential diagnosis of the disorder, according to a report in the Nov. 26 issue of the New England Journal of Medicine.

Chronic Musculoskeletal Pain Raises Risk of Falling in Elderly

Posted by Admin | Posted in Medical Lawyers | Posted on 25-11-2009

Chronic musculoskeletal pain raises elderly peoples risk of falling, independent of their underlying pathologies or the medications they may be taking for the pain, according to a study of more than 700 elders living independently.

Unpublished Research Signaled Rofecoxib CV Risk as Early as 2001, Study Alleges

Posted by Admin | Posted in Medical Lawyers | Posted on 24-11-2009

Tamiflu-Resistant H1N1 Influenza Found in Wales

Posted by Admin | Posted in Medical Lawyers | Posted on 22-11-2009

The British Health Protection Agency has confirmed five patients with oseltamivir-resistant pandemic influenza A(H1N1) virus on a hospital ward in Wales.

ACOG Recommends Changes in Cervical Screening

Posted by Admin | Posted in Medical Lawyers | Posted on 20-11-2009

The American College of Obstetricians and Gynecologists announced Nov. 20 that it is now recommending delaying the start of cervical cancer screening until age 21 and then screening most patients every other year instead of annually.

FDA Panel Recommends Approval of Pneumococcal Disease Vaccine

Posted by Admin | Posted in Medical Lawyers | Posted on 19-11-2009

BETHESDA, Md. (EGMN) A Food and Drug Administration advisory panel voted on Nov. 18 in favor of recommending Pfizers 13-valent pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease.

U.S. Senate Holds Hearing on H1N1 Vaccine Shortages

Posted by Admin | Posted in Medical Lawyers | Posted on 18-11-2009

The U.S. Senates Homeland Security and Governmental Affairs Committee held a hearing Nov. 17 to determine why vaccine for pandemic influenza A(H1N1) virus is taking so long to reach the 159 million Americans in the designated high-risk groups.

Guidelines for Stage IV NSCLC Edge Toward Individualized Therapy Choices

Posted by Admin | Posted in Medical Lawyers | Posted on 17-11-2009

The first substantial revisions in the American Society of Clinical Oncologys clinical guideline for the treatment of stage IV nonsmall cell lung cancer in 6 years acknowledges the burgeoning role for individualization of therapy according to patient characteristics, including epidermal growth factor receptor mutation status and performance status rather than age.

FDA Approves Oral Menorrhagia Therapy

Posted by Admin | Posted in Medical Lawyers | Posted on 14-11-2009

The Food and Drug Administration on Nov. 13 approved Lysteda, a proprietary form of tranexamic acid, for the treatment of menorrhagia.